Teyi Pharmaceutical Group Co.,Ltd reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 384.94 million compared to CNY 358.09 million a year ago. Revenue was CNY 385.14 million compared to CNY 358.24 million a year ago.

Net income was CNY 61.46 million compared to CNY 75.31 million a year ago. Basic earnings per share from continuing operations was CNY 0.2 compared to CNY 0.2643 a year ago. Diluted earnings per share from continuing operations was CNY 0.2 compared to CNY 0.2643 a year ago.